Allantoin

Allantoin has been extracted from comfrey root for over a century. Yet most people who see it listed in a toothpaste have no idea what it actually does there. The short answer: it accelerates recovery of damaged mucosal tissue — and there is a mechanism behind that, not just a marketing claim.

What allantoin is

Allantoin is a diureide of glyoxylic acid. A small organic molecule that forms naturally through the oxidation of uric acid. In most mammals, allantoin is the final product of purine metabolism: the liver breaks purines down to uric acid, and the enzyme urate oxidase converts it further into allantoin. Humans lack a functional version of that enzyme — so we excrete uric acid directly, and allantoin is virtually absent from human blood.

Industrially, allantoin is produced in two ways: by extraction from comfrey root (Symphytum officinale) or by chemical synthesis from glyoxylic acid. Both forms are molecularly identical and functionally equivalent. The difference is origin, not properties.

How healing happens

A 2010 Brazilian study (Araújo et al., PubMed 20877959) was the first to document the histological healing profile induced by allantoin in an experimental model. The authors showed that allantoin accelerates tissue repair through two parallel processes: regulation of the inflammatory response and stimulation of fibroblast proliferation.

The mechanism involves several linked steps:

Cell proliferation. Allantoin stimulates division of keratinocytes and fibroblasts — the cells responsible for epithelial repair and collagen synthesis. In in vitro experiments, fibroblasts treated with allantoin showed increased DNA synthesis and mitotic activity.

Inflammation regulation. Allantoin reduces levels of pro-inflammatory cytokines — TNF-α and IL-6. It is believed to suppress NF-κB signaling in immune cells, thereby reducing oxidative stress in the tissue.

Extracellular matrix synthesis. Early collagen deposition in damaged areas is linked to allantoin's activating effect on fibroblastic proliferation. This accelerates the formation of granulation tissue and epithelialization.

"The wound healing mechanism induced by allantoin occurs via the regulation of the inflammatory response and the stimulus to fibroblastic proliferation." — Araújo LU et al., Acta Cirúrgica Brasileira, 2010.

One important qualification: a 2011 study (Hammad et al., Int J Dent Hyg) using an oral wound model in rats found no statistically significant effect of 0.5% allantoin on excisional wound healing in the oral cavity. The authors noted it produced neither positive nor negative results. This matters: the evidence from skin models and oral mucosa models does not fully align, and the application context should be understood.

Allantoin in gum inflammation

In gingivitis and early periodontitis, gingival tissue is under constant irritation. Bacterial biofilm drives chronic inflammation: capillaries dilate, tissues swell, the epithelium thins, bleeding appears. Here, allantoin does not work as an antiseptic — it does not kill bacteria. Its role is different: to reduce the intensity of the inflammatory reaction and accelerate regeneration of the irritated epithelium.

In this context, allantoin serves as a soothing and healing component in toothpastes, rinses, and gels designed for gum care. At 0.1–0.5% concentration it provides a functional effect without risk of adverse reactions.

Synergy with antiseptics

Allantoin pairs well with antiseptic actives. The logic is straightforward: an antiseptic — CPC (cetylpyridinium chloride) or chlorhexidine — suppresses bacterial load by removing the cause of inflammation. Allantoin meanwhile addresses the consequences — helping irritated mucosa recover faster.

The same synergy works with zinc. Zn²⁺ ions inhibit bacterial enzymatic activity and slow plaque formation, while allantoin provides the regenerative background. The result is a formula working simultaneously in two directions: prevention and recovery.

Worth noting separately: allantoin is compatible with sage and other botanical extracts with astringent properties. It compensates for any dryness that tannins can create in the mucosa.

Safety

The CIR (Cosmetic Ingredient Review) Expert Panel conducted a full toxicological review of allantoin and its complexes in 2010. Conclusion: allantoin is safe for use in cosmetic products at current concentrations in use. It is not a mutagen, sensitizer, or irritant at standard cosmetic concentrations. Not phototoxic.

The FDA permits allantoin as an active ingredient in OTC skin protectant products at 0.5–2%. Oral care applications use considerably lower concentrations — 0.1–0.2% — well within the established safety profile.

Allantoin is well tolerated by dry, sensitive, and inflamed mucosa alike. No data exist indicating accumulation, resistance, or adverse interactions with standard toothpaste components.

---

Sources:

• Araújo LU et al. Profile of wound healing process induced by allantoin. Acta Cir Bras. 2010;25(5). PubMed 20877959
• Hammad HM et al. Effects of topically applied agents on intra-oral wound healing in a rat model. Int J Dent Hyg. 2011;9(1):9-16. PubMed 21226845
• Becker LC et al. Final Report of the Safety Assessment of Allantoin and Its Related Complexes. Int J Toxicol. 2010;29(3 Suppl):84S-97S. doi:10.1177/1091581810362805
• Wohlrab J, Kreft D. An investigation into multifaceted mechanisms of action of allantoin in wound healing. J Am Acad Dermatol. 2017. JAAD abstract